What should we do about overweight and obesity?
Author: Ian D Caterson
Published online: 6 December 1999
|
The Weight Debate What should we do about overweight and obesity? The goals of treatment should not necessarily be to normalise weight, but to optimise health |
![]() MJA 1999; 171: 599-600 |
|
Introduction -
Why are we getting obese? -
Why have we not been effective in treating obesity? -
What should we do about obesity? -
What has been ignored is our environment
| |
References
- McLennan W, Podger A. National Nutrition Survey -- Selected Highlights Australia. Canberra: Australian Bureau of Statistics and Department of Health and Family Services, 1997.
- Obesity: preventing and managing the global epidemic. Report of a WHO consultation on obesity, Geneva, 3-5 June, 1997. WHO: Geneva, 1997.
- National Health and Medical Research Council. Acting on Australia's weight. The Report of the NHMRC Working Party on the prevention of overweight and obesity. Canberra: NHMRC, 1996.
- Dupen F, Bauman A, Lin R. The source of risk factor information for general practitioners: is physical activity under-recognised? Med J Aust 1999; 171: 601-603.
- Physical activity and health: a report of the Surgeon General. Atlanta, Md: US Department of Health and Human Services, Centers for Disease Control, 1996.
- National Physical Activity Guidelines for Australians. Canberra: Commonwealth Department of Health and Aged Care, 1999.
- Wing RR, Greeno CG. Behavioural and psychosocial aspects of obesity. Clin Endocrinol Metab 1994; 8: 689-703.
- Egger G, Cameron-Smith D, Stanton R. The effectiveness of popular, non- prescription weight loss supplements. Med J Aust 1999; 171: 604-608.
- Burry JN. Obesity and virtue. Is staying lean a matter of ethics? Med J Aust 1999; 171: 609-610.
- Proietto J. Why staying lean is not a matter of ethics. Med J Aust 1999; 171: 611-613.
- Goldstein DJ. Beneficial health effects of modest weight loss. Int J Obes 1991; 16: 397-415.
- Sjostrom L, Rissanen A, Andersen T, et al. Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. Lancet 1998; 352: 167-172.
- McNeely W, Goa KL. Sibutramine. A review of its contribution to management. Drugs 1998; 56: 1093-1124.
- Egger G, Swinburn B. An "ecological" approach to the obesity pandemic. BMJ 1997; 315: 477-480.
